Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresse… Read more
Market Cap & Net Worth: Autonomix Medical, Inc. Common Stock (AMIX)
Autonomix Medical, Inc. Common Stock (NASDAQ:AMIX) has a market capitalization of $5.17 Million ($5.17 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31299 globally and #10299 in its home market, demonstrating a 4.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Autonomix Medical, Inc. Common Stock's stock price $0.45 by its total outstanding shares 11409344 (11.41 Million).
Autonomix Medical, Inc. Common Stock Market Cap History: 2024 to 2026
Autonomix Medical, Inc. Common Stock's market capitalization history from 2024 to 2026. Data shows change from $43.70 Million to $5.17 Million (-92.10% CAGR).
Index Memberships
Autonomix Medical, Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #805 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2551 of 3165 |
Weight: Autonomix Medical, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Autonomix Medical, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Autonomix Medical, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AMIX by Market Capitalization
Companies near Autonomix Medical, Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Autonomix Medical, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Autonomix Medical, Inc. Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Autonomix Medical, Inc. Common Stock's market cap moved from $43.70 Million to $ 5.17 Million, with a yearly change of -92.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.17 Million | -17.64% |
| 2025 | $6.28 Million | -85.64% |
| 2024 | $43.70 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Autonomix Medical, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.17 Million USD |
| MoneyControl | $5.17 Million USD |
| MarketWatch | $5.17 Million USD |
| marketcap.company | $5.17 Million USD |
| Reuters | $5.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.